TP53 and colorectal carcinoma: A possible mechanism might involve enhancement of the PG-induced restoration of the p53 pathway known to target CRC stem cells which represent a considerable proportion of HCT116 cells via activation of p73, a member of the p53 family [36], leading to cell growth inhibition.